BLUE BELL, PA–The Canadian Life Science and Technology Park, Allyant, and IPS announced a strategic, multi-year partnership focused on the advancement of the design and engineering of a state-of-the-art Life Science, Healthcare, and Technology Park.
This collaboration brings together expertise in design and construction oversight tailored for specialized turnkey startups, commercial manufacturing, and comprehensive support facilities.
In the initial phase, this collaborative effort will begin with the development and site master planning of a 56-acre site in Georgina, Ontario, situated within the Keswick Business Park. This park aims to serve a wide array of sectors, attracting tenants and clients from pharmaceutical, biotechnology, medical device, bioprocessing, Contract Research Organizations (CROs), Contract Development and Manufacturing Organizations (CDMOs), warehousing, healthcare, academia, digital and technology sectors, and other related fields.
“Our collaboration with Allyant and the IPS Canadian team is designed to create an innovative, capital-efficient, and sustainable model. This approach is vital for developing the infrastructure needed to expedite the process of developing, testing, and delivering transformative services and medicines to patients,” remarked Safa’a Al-Rais, President and CEO of the Canadian Life Science and Technology Park.
The Canadian Life Science and Technology Park is committed to linking the Life Science and Technology industries within a 56-acre advanced space. Its mission is to establish a vibrant ecosystem that connects startups with established commercial enterprises. By integrating real estate, people, ideas, machinery, systems, and data into a cohesive network, the park aims to create an agile and efficient environment conducive to development and manufacturing, aligning with the latest Industry and Pharma 4.0 innovations.
